Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
Leukemia
|
April 9, 2021
Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia
Cedric Schleiss, Raphael Carapito, Luc-Matthieu Fornecker, et al.
Bone Marrow Transplantation
|
February 12, 2022
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
Domitille Costes-Tertrais, Thomas Hueso, Thomas Gastinne, et al.
Bone Marrow Transplantation
|
January 22, 2020
Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin
Pierre-Edouard Debureaux, Delphine Le Febvre de Nailly, Emmanuelle Tavernier, et al.
Blood Advances
|
April 12, 2021
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, et al.
Haematologica
|
September 20, 2015
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)
Laurence Simon, Aikaterini Fitsiori, Richard Lemal, et al.
British Journal of Haematology
|
April 26, 2025
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2021
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
Isabelle Demeestere, Judith Racape, Julie Dechene, et al.
Haematologica
|
October 21, 2016
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
Monique C Minnema, Eva Kimby, Shirley D'Sa, et al.
Haematologica
|
October 3, 2015
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
Julien Lazarovici, Peggy Dartigues, Pauline Brice, et al.
Haematologica
|
May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
Cédric Rossi, Marc André, Jehan Dupuis, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
Leukemia
|
April 9, 2021
Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia
Cedric Schleiss, Raphael Carapito, Luc-Matthieu Fornecker, et al.
Bone Marrow Transplantation
|
February 12, 2022
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
Domitille Costes-Tertrais, Thomas Hueso, Thomas Gastinne, et al.
Bone Marrow Transplantation
|
January 22, 2020
Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin
Pierre-Edouard Debureaux, Delphine Le Febvre de Nailly, Emmanuelle Tavernier, et al.
Blood Advances
|
April 12, 2021
The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA
Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, et al.
Haematologica
|
September 20, 2015
Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO)
Laurence Simon, Aikaterini Fitsiori, Richard Lemal, et al.
British Journal of Haematology
|
April 26, 2025
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2021
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011)
Isabelle Demeestere, Judith Racape, Julie Dechene, et al.
Haematologica
|
October 21, 2016
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
Monique C Minnema, Eva Kimby, Shirley D'Sa, et al.
Haematologica
|
October 3, 2015
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
Julien Lazarovici, Peggy Dartigues, Pauline Brice, et al.
Haematologica
|
May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
Cédric Rossi, Marc André, Jehan Dupuis, et al.
Page
of 8